BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 36652592)

  • 21. Evidence of altered mucosa-associated and fecal microbiota composition in patients with Irritable Bowel Syndrome.
    Sundin J; Aziz I; Nordlander S; Polster A; Hu YOO; Hugerth LW; Pennhag AAL; Engstrand L; Törnblom H; Simrén M; Öhman L
    Sci Rep; 2020 Jan; 10(1):593. PubMed ID: 31953505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of gut microbiota of iranian patients with celiac disease, non-celiac wheat sensitivity, and irritable bowel syndrome: are there any similarities?
    Naseri K; Dabiri H; Olfatifar M; Shahrbaf MA; Yadegar A; Soheilian-Khorzoghi M; Sadeghi A; Saadati S; Rostami-Nejad M; Verma AK; Zali MR
    BMC Gastroenterol; 2023 Jan; 23(1):15. PubMed ID: 36647022
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis.
    Labus JS; Osadchiy V; Hsiao EY; Tap J; Derrien M; Gupta A; Tillisch K; Le Nevé B; Grinsvall C; Ljungberg M; Öhman L; Törnblom H; Simren M; Mayer EA
    Microbiome; 2019 Mar; 7(1):45. PubMed ID: 30898151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender Influences Gut Microbiota among Patients with Irritable Bowel Syndrome.
    Pecyna P; Gabryel M; Mankowska-Wierzbicka D; Nowak-Malczewska DM; Jaskiewicz K; Jaworska MM; Tomczak H; Rydzanicz M; Ploski R; Grzymislawski M; Dobrowolska A; Gajecka M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colonic mucosal microbiota is associated with bowel habit subtype and abdominal pain in patients with irritable bowel syndrome.
    Choo C; Mahurkar-Joshi S; Dong TS; Lenhart A; Lagishetty V; Jacobs JP; Labus JS; Jaffe N; Mayer EA; Chang L
    Am J Physiol Gastrointest Liver Physiol; 2022 Aug; 323(2):G134-G143. PubMed ID: 35726867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fecal and Mucosa-Associated Intestinal Microbiota in Patients with Diarrhea-Predominant Irritable Bowel Syndrome.
    Maharshak N; Ringel Y; Katibian D; Lundqvist A; Sartor RB; Carroll IM; Ringel-Kulka T
    Dig Dis Sci; 2018 Jul; 63(7):1890-1899. PubMed ID: 29777439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Visceral hypersensitive rats share common dysbiosis features with irritable bowel syndrome patients.
    Zhou XY; Li M; Li X; Long X; Zuo XL; Hou XH; Cong YZ; Li YQ
    World J Gastroenterol; 2016 Jun; 22(22):5211-27. PubMed ID: 27298564
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No distinct microbiome signature of irritable bowel syndrome found in a Swedish random population.
    Hugerth LW; Andreasson A; Talley NJ; Forsberg AM; Kjellström L; Schmidt PT; Agreus L; Engstrand L
    Gut; 2020 Jun; 69(6):1076-1084. PubMed ID: 31601615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
    Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
    Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
    [No Abstract]   [Full Text] [Related]  

  • 31. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID).
    Vasapolli R; Schulz C; Schweden M; Casèn C; Kirubakaran GT; Kirste KH; Macke L; Link A; Schütte K; Malfertheiner P
    Eur J Clin Invest; 2021 Dec; 51(12):e13666. PubMed ID: 34390492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.
    Casén C; Vebø HC; Sekelja M; Hegge FT; Karlsson MK; Ciemniejewska E; Dzankovic S; Frøyland C; Nestestog R; Engstrand L; Munkholm P; Nielsen OH; Rogler G; Simrén M; Öhman L; Vatn MH; Rudi K
    Aliment Pharmacol Ther; 2015 Jul; 42(1):71-83. PubMed ID: 25973666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Systematic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups.
    Teige ES; Sortvik U; Lied GA
    Clin Exp Gastroenterol; 2024; 17():109-120. PubMed ID: 38646157
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.
    Codling C; O'Mahony L; Shanahan F; Quigley EM; Marchesi JR
    Dig Dis Sci; 2010 Feb; 55(2):392-7. PubMed ID: 19693670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbiota in mucosa and feces of newly diagnosed, treatment-naïve adult inflammatory bowel disease and irritable bowel syndrome patients.
    Čipčić Paljetak H; Barešić A; Panek M; Perić M; Matijašić M; Lojkić I; Barišić A; Vranešić Bender D; Ljubas Kelečić D; Brinar M; Kalauz M; Miličević M; Grgić D; Turk N; Karas I; Čuković-Čavka S; Krznarić Ž; Verbanac D
    Gut Microbes; 2022; 14(1):2083419. PubMed ID: 35695669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intestinal Fungal Dysbiosis Is Associated With Visceral Hypersensitivity in Patients With Irritable Bowel Syndrome and Rats.
    Botschuijver S; Roeselers G; Levin E; Jonkers DM; Welting O; Heinsbroek SEM; de Weerd HH; Boekhout T; Fornai M; Masclee AA; Schuren FHJ; de Jonge WJ; Seppen J; van den Wijngaard RM
    Gastroenterology; 2017 Oct; 153(4):1026-1039. PubMed ID: 28624575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations in fecal β-defensin-3 secretion as a marker of instability of the gut microbiota.
    Saqib Z; De Palma G; Lu J; Surette M; Bercik P; Collins SM
    Gut Microbes; 2023; 15(1):2233679. PubMed ID: 37464450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Carroll IM; Ringel-Kulka T; Siddle JP; Ringel Y
    Neurogastroenterol Motil; 2012 Jun; 24(6):521-30, e248. PubMed ID: 22339879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
    J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome.
    Chassard C; Dapoigny M; Scott KP; Crouzet L; Del'homme C; Marquet P; Martin JC; Pickering G; Ardid D; Eschalier A; Dubray C; Flint HJ; Bernalier-Donadille A
    Aliment Pharmacol Ther; 2012 Apr; 35(7):828-38. PubMed ID: 22315951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.